StockData
Boston Scientific Corp logo

Boston Scientific Corp

BSXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 14/3054% below fair value
$42.99−0.65 (-1.49%)

Close on Nov 19, 2026Market cap $62.30BP/E 17.4Yield –

Boston Scientific Stock-Based Compensation Expense by Quarter

Stock-Based Compensation Expense ($M) ($M)

Boston Scientific Stock-Based Compensation Expense: $72M in Q3 2026, down 8.9% from a year earlier.

Latest, Q3 2026
72
Period ended Sep 30, 2026
Change on a year earlier
-8.9%
79 in Q3 2025
History
66 quarters
Since Q1 2009
Sources
61
Documents cited below

Where the Q3 2026 figure comes from

Calculated from reported figures: quarter = year-to-date − previous year-to-date (cash flow statement)

Source: Form 10-Q (filed 2026-11-02) ↗

Reported in SEC Form 10-K & 10-Q GAAP Financial Statements (Database).

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedStock-Based Compensation Expense ($M) ($M)Year on yearSource
Q3 2026Sep 30, 202672-8.9%Form 10-Q (filed 2026-11-02) ↗
Q2 2026Jun 30, 202687+16.0%Form 10-Q (filed 2026-08-03) ↗
Q1 2026Mar 31, 202683+12.2%Form 10-Q (filed 2026-05-01) ↗
Q4 2025Dec 31, 202571+2.9%Form 10-K (filed 2026-02-17) ↗
Q3 2025Sep 30, 202579+16.2%Form 10-Q (filed 2025-11-03) ↗
Q2 2025Jun 30, 202575+13.6%Form 10-Q (filed 2025-08-01) ↗
Q1 2025Mar 31, 202574+17.5%Form 10-Q (filed 2025-05-01) ↗
Q4 2024Dec 31, 202469+16.9%Form 10-K (filed 2025-02-18) ↗
Q3 2024Sep 30, 202468+15.3%Form 10-Q (filed 2024-11-01) ↗
Q2 2024Jun 30, 202466+10.0%Form 10-Q (filed 2024-08-01) ↗
Q1 2024Mar 31, 202463+14.5%Form 10-Q (filed 2024-05-01) ↗
Q4 2023Dec 31, 202359+7.3%Form 10-K (filed 2024-02-20) ↗
Q3 2023Sep 30, 202359+1.7%Form 10-Q (filed 2023-11-01) ↗
Q2 2023Jun 30, 202360+9.1%Form 10-Q (filed 2023-08-03) ↗
Q1 2023Mar 31, 202355+5.8%Form 10-Q (filed 2023-05-04) ↗
Q4 2022Dec 31, 202255+12.2%Form 10-K (filed 2023-02-23) ↗

Cite this data

StockData. (2026). Boston Scientific Stock-Based Compensation Expense ($M), quarterly Q1 2009–Q3 2026 [Data set]. Compiled from Boston Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/bsx/kpis/db-cf-sbc

See every metric in the Boston Scientific KPI table. Data updated Nov 4, 2026.

See a number that looks wrong?